Effects of short-term streptozotocin-induced diabetes and vitamin C on platelet non-enzymatic glycation

Pathophysiology of Haemostasis and Thrombosis

Volumn 37, Issue 2-4, 2009, Pages 72-76

  Batirel, Saime ^a   Yarat, Ayşen ^b   Emekli, Nesrin ^b  

^a ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Diabetes; Glycation; Platelet; Streptozotocin; Vitamin C

Indexed keywords

ASCORBIC ACID; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; THROMBOCYTE;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; BLOOD PLATELETS; DIABETES MELLITUS, EXPERIMENTAL; GLYCOSYLATION; MALE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; TIME FACTORS;

EID: 79957957238     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000322916     Document Type: Article

References (35)

1. Hudson BI, Hoffmann MA, Bucciarelli L, Wendt T, Moser B, Lu Y, Qu W, Stern DM, D'Agati V, Yan SD, Van SF, Grant PJ, Schmidt M: Glycation and diabetes: The RAGE connection. Curr Sci 2002; 83: 1515-1521. (Pubitemid 135698200)
2. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW, Lyons TJ: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993; 91: 2470-2478. (Pubitemid 23182498)
3. Dyer DG, Dunn JA, Thorpe SR, Beilie KE, Lyons TJ, Mc Cance DR, Boynes JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993; 91: 2463-2469. (Pubitemid 23182497)
4. Kagami K, OndaK, Oka K, Hirano T: Suppression of blood lipid concentrations by volatile Maillard reaction products. Nutrition 2008; 24: 1159-1166.
5. Wautier JL, Guillausseau PJ: Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001; 27: 535-542. (Pubitemid 33051702)
6. Ahmed N: Advanced glycation end products: Role in pathology of diabetic complications. Diabetes Res Clin Pract 2005; 67: 3-21. (Pubitemid 40037725)
7. Arjomand H, Roukoz B, Surabhi SK, Cohen M: Platelets and antiplatelet therapy in patients with diabetes mellitus. J Invest Cardiol 2003; 15: 264-269. (Pubitemid 36576600)
8. Yamagishi S, Nakamura K, Imaizumi T: Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev 2005; 1: 93-106.
9. Wardlow GM, Insel PM: The water soluble vitamins; in Wardlow GM, Insel PM: Perspectives in Nutrition, ed 3. St Louis, Mosby, 1995, pp 437-479.
10. Zhou A, Thorn NA: High ascorbic acid content in the rat endocrine pancreas. Diabetologia 1991; 34: 839-842.
11. Zhou A, Nielsen JH, Farver O, Thorn NA: Transport of ascorbic acid and dehydroascorbic acid by pancreatic islets from neonatal rats. Biochem J 1991; 274: 739-744.
12. Will JC, Ford ES, Bowman BA: Serum vitamin C concentrations and diabetes: Findings from the Third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999; 70: 49-52. (Pubitemid 29461112)
13. Ross R: Atherosclerosis-inflammatory disease. N Engl J Med 1999; 340: 115-126.
14. Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL: Platelet dysfunction in type 2 diabetes. Diabetes Care 2001; 24: 1476-1485. (Pubitemid 33716440)
15. Junod A, Lambert AE, Stauffacher W, Renold AE: Diabetogenic action of streptozotocin. Relationship of dose to metabolic response. J Clin Invest 1969; 48: 2129-2139.
16. Staven P: Platelet count by phase contrast microscopy - new diluting fluid for better visualization. Scand J Lab Invest 1974; 33: 121-123.
17. Parker KM, England JD, Hassel R, Goldstein PE: Improved colorimetric assay for glycosylated hemoglobin. Clin Chem 1981; 27: 669-672. (Pubitemid 11065664)
18. Lowry OH, Rosebrough WI, Farr Al, Randal RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Brewster MA, Turley CP: Vitamin C; in Pesce AJ, Kaplan LA (eds): Methods in Clinical Chemistry. St Louis, Mosby, 1987, pp 574-581.
20. Tietz NW: Fundamentals of Clinical Chemistry, ed 3. Philadelphia, Saunders, 1987, p 513.
21. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: Epidemiology, pathophysiology and management. JAMA 2002; 287: 2570-2581. (Pubitemid 34517204)
22. Carr ME: Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 2001; 15: 44-54. (Pubitemid 32203891)
23. Mustard JF, Packham MA: Platelets and diabetes mellitus. N Engl J Med 1977; 297: 1345-1347. (Pubitemid 8249127)
24. Winocour PD, Watala C, Kinlough-Rathbone RL: Reduced membrane fluidity and increased glycation of membrane proteins of platelets from diabetic subjects are not associated with increased platelet adherence to glycated collagen. J Lab Clin Med 1992; 120: 921-928. (Pubitemid 23002902)
25. Ferroni P, Basili S, Falco A, Davi G: Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2004; 2: 1282-1291. (Pubitemid 40186123)
26. Sinclair AJ, Taylor PB, Girling AJ: Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med 1994; 11: 893-901.
27. Will JC, Byers T: Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 1996: 54: 193-202. (Pubitemid 26364539)
28. Noctor G, Foyer C: Ascorbate and glutathione: Keeping active oxygen under control. Annu Rev Plant Mol Biol 1998; 49: 249-279.
29. Sargeant LA, Wareham NJ, Bingham S, Day NE, Luben RN, Oakes S, Welch A, Khaw KT: Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer- Norfolk (EPIC-Norfolk) study: A population based study. Diabetes Care 2000; 23: 726-732. (Pubitemid 30414183)
30. Yasser HA, Finbarr PM, Money MH, Barnett CR, Flatt PR: Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. Metabolism 2002; 51: 514-517. (Pubitemid 34406571)
31. Weykamp CW, Penders TJ, Baadenhuijsen FA, Muskiet WM, van der Slik W: Vitamin C and glycohemoglobin. Clin Chem 1995; 41: 713-716.
32. Ely JTA: Unrecognized pandemic subclinical diabetes of the affluent nations: Causes, cost and prevention. J Orthomolecular Med 1996; 11: 95-99. (Pubitemid 26272970)
33. Sarji KE, Kleinfelder J, Brewington P, Gonzalez J, Hempling H, Colwell JA: Decreased platelet vitamin C in diabetes mellitus: Possible role in hyperaggregation. Thromb Res 1979; 15: 639-650. (Pubitemid 10237131)
34. Ortwerth BJ, Slighta SH, Prabhakarama M, Sunb Y, Smithb YB: Site-specific glycation of lens crystallins by ascorbic acid. Biochim Biophys Acta 1992; 1117: 207-215.
35. Prabhakarama M, Ortwertha BJ: The glycation- associated crosslinking of lens proteins by ascorbic acid is not mediated by oxygen free radicals. Exp Eye Res 1991; 53: 261-268.